缺乏症对心力衰竭患者根据射出分数亚型的影响 - 一项观察性研究
Yu Hirao1, Hirokazu Shiraishi1, Tomotsugu Seki1
1Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine Kyoto Japan.
Circulation reports
|February 11, 2026
概括
缺乏在心力衰竭 (HF) 中很常见,并且与更糟糕的结果有关. 这项研究发现,缺乏预示着预后不佳,特别是在具有保留射出分数 (HFpEF) 的HF中.
科学领域:
- 心脏病学 心脏病学
- 营养科学 营养科学
背景情况:
- 缺乏症在心力衰竭 (HF) 患者中很普遍.
- 这种缺陷可能会加剧病情的预后.
研究的目的:
- 研究HF患者的含量与临床指数之间的相关性.
- 评估缺乏对HF的一年结果的影响.
主要方法:
- 在2016年至2019年期间住院的157名高频率患者的回顾性分析.
- 缺乏症定义为≤60μg/dL.
- 检查和临床指数之间的相关性,包括贫血,营养不良和肌肉指数,以及一年死亡率和再接收率.
主要成果:
- 缺乏与贫血,营养不良和肌肉指数下降相关,独立于饮食摄入量.
- 缺乏症患者的死亡率/再入院率显著高 (43%对25%,P=0.027).
- 这种关联在HF具有保存的射出分数 (HFpEF) 中尤为明显,其率为62%与26% (P=0.01).
结论:
- 缺乏是心力衰竭患者预后不佳的重要预测因素.
- 这些发现强调了缺乏作为风险分层的潜在简单生物标志物,特别是在HFpEF中.
- 解决水平可能对于改善高温管理结果至关重要.
相关概念视频
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management
360
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360


